virtual group speech therapy intervention guided by a patient partner
virtual group speech therapy intervention guided by a patient partner: virtual group speech therapy intervention guided by a patient partner
Study summary
This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for head and neck cancer.
The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a patient partner. This intervention has the potential to improve quality of care, accessibility to services and optimize health care resources.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adults ≥ 18 years of age with a diagnosis of head or neck cancer
* Chemoradiotherapy treatments planned for curative purposes
* Planned external radiation therapy dose of at least ≥60 Grays
* Sufficient proficiency in French to complete self-reported questionnaires
Exclusion Criteria:
* Remote metastases
* Previous or planned total laryngectomy
* Previous moderate/severe dysphagia known and/or evaluated by speech therapy
* Diagnosis of a second synchronous cancer at the time of study enrollment
* History of prior radiation therapy to the head and neck area
* Have a cognitive impairment (diagnosed or suspected) that may significantly interfere with participation in the intervention and various measurement procedures.
Primary outcome measure(s)
Rate of nasogastric tube — within 6 weeks post radiation To evaluate the rate of nasogastric tube placement in the acute and subacute period in patients who participated in the group intervention.
Trial sites (1)
Facility
City
Region
Status
Centre Hospitalier de l'Université de Montréal
Montreal
Quebec
Recruiting
More Centre hospitalier de l'Université de Montréal (CHUM) trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.